Aberrant CpG-island methylation has non-random and tumour-type-specific patterns.
about
Aberrant DNA methylation of OLIG1, a novel prognostic factor in non-small cell lung cancerDNA methylation profiling of the human major histocompatibility complex: a pilot study for the human epigenome projectMiR-185 targets the DNA methyltransferases 1 and regulates global DNA methylation in human gliomaEpigenetic inactivation and aberrant transcription of CSMD1 in squamous cell carcinoma cell lines.Tumour class prediction and discovery by microarray-based DNA methylation analysisHLTF gene silencing in human colon cancer.The retinoblastoma gene product interacts with maintenance human DNA (cytosine-5) methyltransferase and modulates its activityQuantitative high-throughput analysis of DNA methylation patterns by base-specific cleavage and mass spectrometryEpigenetic regulation of the tumor suppressor gene TCF21 on 6q23-q24 in lung and head and neck cancer.Epigenetic silencing of the protocadherin family member PCDH-gamma-A11 in astrocytomasIdentification and characterization of the potential promoter regions of 1031 kinds of human genesTherapeutic Implications of Targeting AKT Signaling in MelanomaLoss of expression of HDAC-recruiting methyl-CpG-binding domain proteins in human cancerEpigenetics as a mechanism driving polygenic clinical drug resistanceEpigenetic changes during disease progression in a murine model of human chronic lymphocytic leukemiaExpression of sprouty2 inhibits B-cell proliferation and is epigenetically silenced in mouse and human B-cell lymphomasSLC5A8, a sodium transporter, is a tumor suppressor gene silenced by methylation in human colon aberrant crypt foci and cancersAn AscI boundary library for the studies of genetic and epigenetic alterations in CpG islandsGenetic alteration and gene expression modulation during cancer progressionCharacteristic promoter hypermethylation signatures in male germ cell tumorsFrequent promoter methylation of CDH1, DAPK, RARB, and HIC1 genes in carcinoma of cervix uteri: its relationship to clinical outcomeSuppression of metallothionein-I/II expression and its probable molecular mechanismsDysregulated transcriptional and post-translational control of DNA methyltransferases in cancerFolate and DNA methylation: a review of molecular mechanisms and the evidence for folate's roleCytosine modifications in neurodevelopment and diseasesEpigenetics advancing personalized nanomedicine in cancer therapymiRNA-based therapies: strategies and delivery platforms for oligonucleotide and non-oligonucleotide agentsEpigenetics in Cancer: A Hematological PerspectiveEpigenetics and Common Ophthalmic DiseasesEmerging technologies for studying DNA methylation for the molecular diagnosis of cancerEpigenetic silencing of the HIC-1 gene in human medulloblastomasGlobal methylation profiling of lung cancer identifies novel methylated genesMethylation matters5-Aza-deoxycytidine induces selective degradation of DNA methyltransferase 1 by a proteasomal pathway that requires the KEN box, bromo-adjacent homology domain, and nuclear localization signalRecurrent epimutations activate gene body promoters in primary glioblastomaMolecular detection of B-cell neoplasms by specific DNA methylation biomarkersA genome-wide screen for promoter methylation in lung cancer identifies novel methylation markers for multiple malignanciesDNA methylation analysis of chromosome 21 gene promoters at single base pair and single allele resolutionDNA methyltransferase inhibitor zebularine induces human cholangiocarcinoma cell death through alteration of DNA methylation statusOverexpression of Ribosomal RNA in the Development of Human Cervical Cancer Is Associated with rDNA Promoter Hypomethylation
P2860
Q21092374-0F1F6FA6-406A-465F-A0E1-6B7EA49232C8Q21146392-DC9A5C6B-1300-4133-A011-BDC5ADEAB5F8Q21245768-7309C7B2-D7D8-446A-BD43-A32AEBAD14FAQ21246015-04BBA3A0-DD5C-4B1B-9E07-B3E6C510DA7CQ24514903-93B11FCF-1899-4A34-8CA7-669CE0F958C4Q24536137-29441F76-251F-46B2-B427-8ABA9C2B53E5Q24536177-E38766B3-CE04-4684-9091-6BB7AE8436E7Q24536837-AE790E95-0D9D-4245-8E9F-99705052058EQ24538785-9FEAC6EA-A1E1-4523-AE26-8E177CB5FEF9Q24550860-4C09F5DA-7D35-4F4F-A001-411762D5B3B6Q24619773-31368093-036D-48EF-86CA-B382F967784FQ24631438-99552178-E63F-4F3B-B8B6-1BD1927A35C3Q24643488-AC242F8E-AC0B-430A-9488-6211FB311756Q24651640-ABA7DFFF-157A-4718-83D7-832AB0242044Q24652017-258A1BA4-FFC6-457D-9549-6AC805C6E8A9Q24657474-1BC0816A-958F-40F9-98CB-B2F1235545A1Q24679642-DEC4575A-E30A-4483-8A0F-FF540A908121Q24682438-600E934D-2B62-4F9D-BFA8-9AA263088006Q24798750-74E1584A-9A76-471B-B9B9-BB885CDD0ACAQ24799928-1AAAD134-A62E-45DE-A0B8-C82D2487850BQ24800480-F5838280-3D4F-409E-92D1-5B6BB30B8478Q24812578-86F305BB-1F34-4796-B53D-D5B068F2791AQ26827297-F339C669-35EB-42FE-BEFA-DC2FF6A4F239Q26852086-69E4C027-B252-4C1F-B1A6-E08C713A7A39Q26852087-D46ADD92-C50E-4CD0-A8DA-B9BBC5D364CBQ27010637-A00643CD-5EE5-4A68-B6ED-3697474936D6Q27023295-F84866B5-DC85-446A-854F-1CEC5DD6597AQ28077082-08BEAFDB-EB0A-4487-9E4D-65F30C789503Q28077626-71F8BF0F-9A23-4DF0-8AD1-23505070BDE3Q28087759-F762584F-F224-403C-B9D4-A092F24E77C5Q28189231-65470B76-2909-4B7D-96B7-4B0E62029373Q28360366-2B69D12E-E5AA-4B4D-BB0E-DCB472B3B12AQ28364163-8D580074-6E80-4908-A1B3-7D91143AA2F5Q28384242-99751610-017B-4108-A2F9-DCDEA963DBB5Q28385236-A05CE796-9885-4340-B5F7-86E98C0E6EC6Q28394142-EF4C32F5-5A6B-4CA4-9FFE-C76DED5CF9F8Q28469084-2CAB2153-0DCE-4A4D-8A87-C3659672364AQ28475023-9F87BAE9-B232-4904-A3D7-2089FA8274F2Q28544885-C64234EC-B0FD-4FD4-9410-F07B35ACDEC7Q28554451-218BEDE1-2B7F-4CFE-9FB0-71DE1C5294CB
P2860
Aberrant CpG-island methylation has non-random and tumour-type-specific patterns.
description
2000 nî lūn-bûn
@nan
2000 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Aberrant CpG-island methylation has non-random and tumour-type-specific patterns.
@ast
Aberrant CpG-island methylation has non-random and tumour-type-specific patterns.
@en
type
label
Aberrant CpG-island methylation has non-random and tumour-type-specific patterns.
@ast
Aberrant CpG-island methylation has non-random and tumour-type-specific patterns.
@en
prefLabel
Aberrant CpG-island methylation has non-random and tumour-type-specific patterns.
@ast
Aberrant CpG-island methylation has non-random and tumour-type-specific patterns.
@en
P2093
P50
P356
P1433
P1476
Aberrant CpG-island methylation has non-random and tumour-type-specific patterns
@en
P2093
Bloomfield CD
Caligiuri MA
Cavenee WK
Costello JF
Feramisco JD
Frühwald MC
Nishikawa R
P2888
P304
P356
10.1038/72785
P407
P577
2000-02-01T00:00:00Z